Higher BMI May Reduce Chemotherapy Response with Breast Cancer

Article

New research indicates that overweight patients with operable breast cancer are less likely than their normal weight peers to achieve a complete pathologic response to neoadjuvant chemotherapy.

Related Videos
Elizabeth Cerceo, MD | Credit: ACP
Ana Maria Lopez, MD, MPH | Credit: Jefferson Health
Timothy Wilt, MD, MPH | Credit: ACP
Related Content
Stock imagery of diabetes related items. | Credit: Fotolia

ACP's New Type 2 Diabetes Guidance Recommends SGLT2is, GLP-1 RAs as Second-Line to Metformin

April 19th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: 2024 ACP Type 2 Diabetes Recommendations

April 19th 2024
Podcast
IBS patient stomach pain | Credit: Sora Shimazaki, Pexels

Putting Patients First: Breaking Stigma, Dispelling Misconceptions to Improve IBS Care

April 19th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

April 17th 2024
Podcast
Study Investigates Optimal COVID-19 Vaccination Timing in Inflammatory Disease

Study Investigates Optimal COVID-19 Vaccination Timing in Inflammatory Disease

April 19th 2024
Article
GPT-4 Nears 'Expert-Level' Performance in Ophthalmology Examination

GPT-4 Nears 'Expert-Level' Performance in Ophthalmology Examination

April 18th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.